本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AN2 Therapeutics, Inc.

1.05
-0.0300-2.78%
盘后1.050.00000.00%13:31 EDT
成交量:6.66万
成交额:7.08万
市值:3,168.45万
市盈率:-0.69
高:1.11
开:1.05
低:1.05
收:1.08
数据加载中...
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/17

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/07/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals